Specifically, we assessed whether sex, microglial activation (i.e., sTREM2), age or genetic predisposition for AD (i.e., ApoE4) are associated with higher levels in p-tau181, and specifically, modulate the Aβ to p-tau axis. This evidence concerns the gene MAPT and Alzheimer disease.